Press Releases

• Anixa Biosciences: Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s More
• Guardant Health: Launch of Single Namespace Group Uniting Leading Technology, Healthcare and Research Institutions to Set Global Standard for Exabyte-Scale Data Access More
• Metagenomi: Presents New Preclinical Data From MGX-001 Hemophilia A Program Supporting Advancement into Clinical Development More 
• Santa Ana Bio: Appointment of Mike Bonney as Chair of the Board More
• Visby Medical: Tackles STI Epidemic With First At-Home FDA-Authorized PCR Test in Partnership With Google Cloud More
• ZAP Surgical: ZAP-Axon Radiosurgery Planning System Receives U.S. FDA 510(k) and E.U. CE Clearance More

Financial News

• Alto Neuroscience: Third Quarter 2025 Financial Results and Recent Business Highlights More
• Annexon: Third Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones More
• Assembly Biosciences: Third Quarter 2025 Financial Results and Recent Updates More
• Codexis Switches CEOs As It Lays Off Workers and Grabs Manufacturing Space in East Bay More*
• Exclusive VC Funding Data from BYTE51, with Special Big4Bio Pricing More
• FibroGen: Third Quarter 2025 Financial Results and Provides Business Update More
• How Adverum and Its Pioneering Gene Therapy Ended Up in a Buyout by Drug Giant Lilly More*
• JPM Week Conference Readiness Packages (Big4Bio Subscriber Discount) More
• Metagenomi: Third Quarter 2025 Financial Results and Announces Strategic Pipeline Prioritization and Leadership Updates More More
• Nkarta: Third Quarter 2025 Financial Results and Corporate Highlights More
• Rezolute: Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) More
• SI-BONE: Financial Results for the Third Quarter 2025 and Raises 2025 Guidance More
• Soleno Therapeutics: Entry Into $100 Million Accelerated Share Repurchase Agreement More
• Terns Pharmaceuticals: Third Quarter 2025 Financial Results and Provides Corporate Updates More
• XOMA Royalty: Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements More

Media/Misc Coverage

• Subscribe to LifeSci Startup for Updates on US Startups More
• The Big4Bio Podcast: Every Moment Matters: Navigating the Complexities of Drug Discovery Podcast

Companies

Career Center

• Feature: The Rise of Fractional Talent in Life Sciences: What to Expect in 2026 More
• ICYMI: CEO’s Perspective: Big Moves Come with Big Responsibility More
• ICYMI: CEO’s Perspective: The High Cost of Job Hopping More
• ICYMI: Elevating Executive Presence: A Blueprint for Life Sciences and Biotech Leaders More
• ICYMI: The Power of Peer Learning - Why Even Top Biotech Leaders Need Mentorship More
• ICYMI: What’s Next in Precision Medicine: Leadership Challenges and Opportunities More
• Novo Nordisk, Pfizer Make Personnel Waves As They Squabble Over Metsera More*  

• BIO-Europe 2025 Nov 11-12
• Copay, Reimbursement and Access Congress (Save 10% with VIP code: 25B4B10) Nov 18-20
• Pharma/Biotech Gross-To-Net Summit (Save 10% with VIP code: 25B4B10) Nov 18-20
• Patient Support Services Congress (Save 10% with VIP code: 25B4B10) Nov 20-21
• Compounding Pharmacy Compliance (Save 10% with VIP code: 25B4B10) Dec 9-10
• Trade and Channel Strategies (Save 10% with VIP code: 25B4B10) Dec 9-11
  
• Advancing Drug Development Forum Dec 11

SF Bay Sponsors